SCHEMBL6875789

SCHEMBL6875789

COc1ccc(N(C)CC2CCOCC2)cc1NC(N)=S

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ CSF1R P07333 3/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ PDE4D Q08499 3/20 0.37
▸ PDE4A P27815 2/20 0.37
▸ PDE4B Q07343 2/20 0.37
▸ PDE4C Q08493 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6874566 0.83 HTT (0.41) HTTPOLBALDH1A1SMN1; SMN2LMNA
SCHEMBL6878386 0.83 EPHX1 (0.51) ALDH1A1SMN1; SMN2LMNAKDM4EMEN1
SCHEMBL6870169 0.79 CSF1R (0.41) CSF1RALDH1A1THRBMEN1KMT2A
SCHEMBL6878390 0.77 MAPT (0.40) HTTCSF1RALDH1A1SMN1; SMN2LMNA
SCHEMBL5713569 0.76 KMT2A (0.37) POLBALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL5044211 0.76 HTT (0.44) HTTPOLBALDH1A1SMN1; SMN2KDM4E
SCHEMBL6875792 0.75 CSF1R (0.38) HTTCSF1RPDE4DPDE4APDE4B
SCHEMBL6867755 0.73 KMT2A (0.44) HTTPOLBCSF1RALDH1A1SMN1; SMN2
SCHEMBL3042603 0.69 ALDH1A1 (0.54) HTTPOLBALDH1A1SMN1; SMN2THRB
SCHEMBL17085567 0.68 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456188-A1 7-AMINO-BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2004-09-15 — — EP disclosed
US-6713499-B2 ADENOSINE RECEPTOR AGONIST HOFFMAN-LA ROCHE INC. 2004-03-30 — — US disclosed
US-20030153566-A1 7-Amino-benzothiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 — — US disclosed
WO-2003053946-A1 7-AMINO-BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2003-07-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153566-A1 7-Amino-benzothiazole derivatives ADORA1, ADORA2A, ADORA3 HTT 2541/4885POLB 3899/4885CSF1R 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback